Rosacea: Procedures and Targeted Therapy
On this page
Direct answer
Unlike the papules and pustules, which surrender to ivermectin 1 per cent cream, metronidazole or azelaic acid plus oral doxycycline, the redness of rosacea is a vascular problem answering only to vasoactive drugs and light-based procedures. Brimonidine 0.33 per cent gel and oxymetazoline 1 per cent cream constrict vessels for hours; pulsed dye laser 585-595 nm and intense pulsed light clear persistent erythema and telangiectasia; and rhinophyma yields to CO2 or Er:YAG resurfacing. Oral doxycycline 40 mg modified-release exploits purely anti-inflammatory, sub-antimicrobial doses — the single fact most quoted from this chapter. In India, the twist is topical steroid misuse: fairness and combination creams produce a steroid-dependent facial dermatitis that mimics and aggravates rosacea.
What you must remember
- Erythema drugs: brimonidine 0.33 per cent gel (alpha-2 agonist) and oxymetazoline 1 per cent cream once daily for transient erythema reduction; rebound worsening has been reported with brimonidine, so counsel on its limits.
- Papulopustular staples: ivermectin 1 per cent cream once daily (Demodex density falls and fares better than metronidazole 0.75-1 per cent twice daily in trials), azelaic acid 15 per cent twice daily as the pregnancy-safe option.
- The magic oral dose: doxycycline 40 mg modified-release daily — anti-inflammatory, sub-antimicrobial, no resistance pressure; conventional 100 mg twice daily works when MR formulation is unavailable.
- Light-based menu: pulsed dye laser 585-595 nm for erythema and telangiectasia; long-pulsed Nd:YAG 1064 nm for deeper, larger-calibre vessels; IPL for background redness in suitable phototypes.
- Rhinophyma correction: CO2 or Er:YAG laser resurfacing and surgical sculpting reshape the phymatous nose; medical therapy alone cannot undo hypertrophy.
- Ocular rosacea: lid hygiene, artificial tears, oral tetracyclines and ciclosporin 0.05 per cent drops — unremitting blepharitis with rosacea deserves ophthalmology co-management.
- Demodex logic: folliculorum density rises in rosacea, and ivermectin's advantage over older agents is the mechanistic bridge examiners reward.
- Indian trap: steroid-rosacea from potent combination creams applied for "fairness" — the treatment is steroid cessation with a warned withdrawal flare, not more steroid.
Building the plan: one patient, three problems
A 46-year-old banker with flushing since his thirties now has persistent centrofacial redness, papules across the nose and forehead, gritty eyes and early bulbous enlargement of the nasal tip. He has used a clobetasol-combination cream nightly for two years — the erythema flares whenever he stops, confirming steroid dependence. Step one is the withdrawal conversation: the next four weeks will look worse before better; emollients and zero therapy replace the cream. Step two, at review: ivermectin 1 per cent cream nightly for papules plus oral doxycycline 40 mg modified-release daily for three months controls inflammatory lesions while his eyes settle with lid hygiene and lubricants. Step three, once inflammation is quiet for months: pulsed dye laser sessions for residual erythema and telangiectasia — treating vessels in inflamed skin wastes both money and light. His nasal contour, still early phymatous change, is reassessed at a year; if hypertrophy progresses, CO2 resurfacing reshapes it. Trigger counselling — sun, heat, alcohol, spicy food — threads through every visit.
Where candidates slip
The doxycycline 40 mg figure trips the unwary: candidates assume antibiotic dosing (100 mg twice daily) is the examined fact, when the sub-antimicrobial modified-release dose is precisely what makes rosacea therapy anti-inflammatory — inhibiting matrix metalloproteinases and neutrophil chemotaxis rather than bacteria. The second slip is treating erythema with anti-inflammatory agents: metronidazole barely touches persistent redness, which needs vasoconstrictor drugs or vascular laser. The third is procedural timing: lasering an actively inflamed, steroid-dependent face produces post-inflammatory pigmentation in Indian skin; quiet the inflammation first. And when the vignette says "used a fairness cream for years, now worse on stopping", the diagnosis being tested is steroid rosacea, and the correct answer is structured withdrawal — not brimonidine, not antibiotics.
Frequently asked questions
Which topical agents target persistent erythema rather than papules?
Brimonidine 0.33 per cent gel and oxymetazoline 1 per cent cream, both alpha-agonist vasoconstrictors applied once daily.
What is the rationale for doxycycline 40 mg modified-release in rosacea?
It delivers anti-inflammatory effects — metalloproteinase and neutrophil inhibition — at sub-antimicrobial levels without driving resistance.
Which laser is first-line for rosacea telangiectasia?
Pulsed dye laser at 585-595 nm, with long-pulsed Nd:YAG reserved for larger and deeper vessels.
How is early rhinophyma managed?
Medical control of inflammation plus CO2 or Er:YAG laser resurfacing or surgical sculpting once hypertrophy is established.
What causes steroid rosacea so commonly in Indian practice?
Misuse of potent topical steroid combination creams on the face, producing a rebound-dependent erythema that worsens on withdrawal.